Psigryph Inc.
Plant-derived nanotechnology for biomolecule delivery
Plant-derived nanotechnology for biomolecule delivery
Psigryph Inc. is a groundbreaking startup focused on revolutionizing the delivery of bioactive molecules across cell membranes using their patent-pending Nanopect™ nanodelivery system. Founded in 2018 and headquartered in Canada, the company has identified promising opportunities in various industries, including Food and Beverage, Agriculture, Pharmaceutical, and Cannabis.
The innovative plant-derived nanostructures and food powders developed by Psigryph have undergone extensive research and are poised to enter the market. They have recently attracted a $99.93K grant investment on 24 October 2023 from the Canadian Food Innovation Network - Innovation Booster. This funding will undoubtedly bolster their efforts as they seek to collaborate with leading companies to enhance human, animal, and environmental health through their groundbreaking technology.
Psigryph Inc.'s commitment to leveraging nanotechnology for biomolecule delivery makes them a compelling prospect for investors looking to support cutting-edge advancements in the biotech space. With a clear market focus, a robust technological foundation, and a demonstrated appetite for collaboration, Psigryph Inc. is set to make a significant mark in the field of bioactive molecule delivery.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $99.93K | 1 | Canadian Food Innovation Network - Innovation Booster | 24 Oct 2023 |
| Grant | Unknown | 1 | Employment and Social Development Canada (ESDC) | 30 May 2023 |
No recent news or press coverage available for Psigryph Inc..
We care about your data, and we'd love to use cookies make your experience better.
